{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T02:04:15Z","timestamp":1793844255396,"version":"4.6.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"crossref","award":["2024AFB079"],"award-info":[{"award-number":["2024AFB079"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"crossref","award":["2024AFB053"],"award-info":[{"award-number":["2024AFB053"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"DOI":"10.1186\/s12903-026-08098-9","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T14:55:05Z","timestamp":1773672905000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prognostic value of NLR versus PLR and LMR in patients with oral squamous cell carcinoma: a meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Jian","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhuang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"issue":"3","key":"8098_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"8098_CR2","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/S1470-2045(24)00458-3","volume":"25","author":"H Rumgay","year":"2024","unstructured":"Rumgay H, Nethan ST, Shah R, Vignat J, Ayo-Yusuf O, Chaturvedi P, Guerra ENS, Gupta PC, Gupta R, Liu S, et al. Global burden of oral cancer in 2022 attributable to smokeless tobacco and areca nut consumption: a population attributable fraction analysis. Lancet Oncol. 2024;25(11):1413\u201323.","journal-title":"Lancet Oncol"},{"issue":"1","key":"8098_CR3","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10\u201345.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"8098_CR4","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/odi.13671","volume":"28","author":"A Wahab","year":"2022","unstructured":"Wahab A, Onkamo O, Pirinen M, Almangush A, Salo T. The budding and depth of invasion model in oral cancer: a systematic review and meta-analysis. Oral Dis. 2022;28(2):275\u201383.","journal-title":"Oral Dis"},{"issue":"7","key":"8098_CR5","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1177\/0022034518762090","volume":"97","author":"G Troiano","year":"2018","unstructured":"Troiano G, Mastrangelo F, Caponio VCA, Laino L, Cirillo N, Lo Muzio L. Predictive prognostic value of tissue-based microrna expression in oral squamous cell carcinoma: a systematic review and meta-analysis. J Dent Res. 2018;97(7):759\u201366.","journal-title":"J Dent Res"},{"issue":"4","key":"8098_CR6","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/bjc.2017.425","volume":"118","author":"A Almangush","year":"2018","unstructured":"Almangush A, Pirinen M, Heikkinen I, M\u00e4kitie AA, Salo T, Leivo I. Tumour budding in oral squamous cell carcinoma: a meta-analysis. Br J Cancer. 2018;118(4):577\u201386.","journal-title":"Br J Cancer"},{"key":"8098_CR7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.oraloncology.2017.07.003","volume":"72","author":"C Rivera","year":"2017","unstructured":"Rivera C, Oliveira AK, Costa RAP, De Rossi T, Paes Leme AF. Prognostic biomarkers in oral squamous cell carcinoma: a systematic review. Oral Oncol. 2017;72:38\u201347.","journal-title":"Oral Oncol"},{"issue":"6","key":"8098_CR8","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883\u201399.","journal-title":"Cell"},{"issue":"3","key":"8098_CR9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ccr.2005.02.013","volume":"7","author":"F Balkwill","year":"2005","unstructured":"Balkwill F, Charles KA, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell. 2005;7(3):211\u20137.","journal-title":"Cancer Cell"},{"issue":"1","key":"8098_CR10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41423-024-01244-9","volume":"22","author":"L Koenderman","year":"2025","unstructured":"Koenderman L, Vrisekoop N. Neutrophils in cancer: from biology to therapy. Cell Mol Immunol. 2025;22(1):4\u201323.","journal-title":"Cell Mol Immunol"},{"issue":"s1","key":"8098_CR11","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1038\/modpathol.2016.121","volume":"30","author":"S M\u00fcller","year":"2017","unstructured":"M\u00fcller S. Oral lichenoid lesions: distinguishing the benign from the deadly. Mod Pathol. 2017;30(s1):S54\u201367.","journal-title":"Mod Pathol"},{"key":"8098_CR12","doi-asserted-by":"publisher","first-page":"1023213","DOI":"10.3389\/fimmu.2022.1023213","volume":"13","author":"X Deng","year":"2022","unstructured":"Deng X, Wang Y, Jiang L, Li J, Chen Q. Updates on immunological mechanistic insights and targeting of the oral lichen planus microenvironment. Front Immunol. 2022;13:1023213.","journal-title":"Front Immunol"},{"issue":"1","key":"8098_CR13","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s12916-020-01817-1","volume":"18","author":"MA Cupp","year":"2020","unstructured":"Cupp MA, Cariolou M, Tzoulaki I, Aune D, Evangelou E, Berlanga-Taylor AJ. Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies. BMC Med. 2020;18(1):360.","journal-title":"BMC Med"},{"issue":"1","key":"8098_CR14","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.critrevonc.2013.03.010","volume":"88","author":"GJ Guthrie","year":"2013","unstructured":"Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol. 2013;88(1):218\u201330.","journal-title":"Crit Rev Oncol Hematol"},{"key":"8098_CR15","doi-asserted-by":"publisher","first-page":"1429559","DOI":"10.3389\/fonc.2024.1429559","volume":"14","author":"Q Wang","year":"2024","unstructured":"Wang Q, Yin X, Wang S, Lu H. Inflammatory markers as prognostic markers in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors: a systematic review and meta-analysis. Front Oncol. 2024;14:1429559.","journal-title":"Front Oncol"},{"issue":"1","key":"8098_CR16","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1186\/s12903-024-05026-7","volume":"24","author":"L Huang","year":"2024","unstructured":"Huang L, Wu W, Hu G. Prognostic value of platelet-to-lymphocyte ratio in patients with oral squamous cell carcinoma: a systematic review and meta-analysis. BMC Oral Health. 2024;24(1):1262.","journal-title":"BMC Oral Health"},{"key":"8098_CR17","doi-asserted-by":"publisher","unstructured":"YangY, Liu R, Ren F, Guo R, Zhang P. Prognostic and clinicopathological significance of neutrophil-to-lymphocyte ratio in patients with oral cancer. Biosci Rep. 2018;38(6). https:\/\/doi.org\/10.1042\/BSR20181550","DOI":"10.1042\/BSR20181550"},{"issue":"4","key":"8098_CR18","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/jop.12688","volume":"47","author":"Y Wang","year":"2018","unstructured":"Wang Y, Wang P, Andrukhov O, Wang T, Song S, Yan C, Zhang F. Meta-analysis of the prognostic value of the neutrophil-to-lymphocyte ratio in oral squamous cell carcinoma. J Oral Pathol Med. 2018;47(4):353\u20138.","journal-title":"J Oral Pathol Med"},{"issue":"3","key":"8098_CR19","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/jop.12832","volume":"50","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Zheng L, Quan L, Du L. Prognostic role of platelet-to-lymphocyte ratio in oral cancer: a meta-analysis. J Oral Pathol Med. 2021;50(3):274\u20139.","journal-title":"J Oral Pathol Med"},{"issue":"44","key":"8098_CR20","doi-asserted-by":"publisher","first-page":"e40182","DOI":"10.1097\/MD.0000000000040182","volume":"103","author":"J Xu","year":"2024","unstructured":"Xu J, Lin Y, Yang J, Xing Y, Xing X. Pretreatment systemic immune-inflammation index and lymphocyte-to-monocyte ratio as prognostic factors in oral cavity cancer: a meta-analysis. Med (Baltim). 2024;103(44):e40182.","journal-title":"Med (Baltim)"},{"key":"8098_CR21","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"8098_CR22","doi-asserted-by":"publisher","first-page":"j4008","DOI":"10.1136\/bmj.j4008","volume":"358","author":"BJ Shea","year":"2017","unstructured":"Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, Moher D, Tugwell P, Welch V, Kristjansson E, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008.","journal-title":"BMJ"},{"key":"8098_CR23","doi-asserted-by":"publisher","unstructured":"WellsGA, Wells G, Shea B, Shea B, O\u2019Connell D, Peterson J, Welch, Losos M, Tugwell P, Ga SW et al. The newcastle-ottawa scale (NOS) for Assessing the quality of nonrandomised studies in meta-analyses. In: 2014;2014. https:\/\/doi.org\/10.3390\/publications14010004","DOI":"10.3390\/publications14010004"},{"key":"8098_CR24","unstructured":"HigginsJ. Cochrane handbook for systematic reviews of interventions. Version 5.1.0. The Cochrane Collaboration. In: 2011;2011. https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/archive\/v5.1.0"},{"issue":"22","key":"8098_CR25","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1200\/JCO.2014.55.2208","volume":"32","author":"H Uno","year":"2014","unstructured":"Uno H, Claggett B, Tian L, Inoue E, Gallo P, Miyata T, Schrag D, Takeuchi M, Uyama Y, Zhao L, et al. Moving beyond the hazard ratio in quantifying the between-group difference in survival analysis. J Clin Oncol. 2014;32(22):2380\u20135.","journal-title":"J Clin Oncol"},{"key":"8098_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2288-12-9","volume":"12","author":"P Guyot","year":"2012","unstructured":"Guyot P, Ades AE, Ouwens MJ, Welton NJ. Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves. BMC Med Res Methodol. 2012;12:9.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"8098_CR27","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1093\/biostatistics\/kxz018","volume":"22","author":"IR Weir","year":"2021","unstructured":"Weir IR, Tian L, Trinquart L. Multivariate meta-analysis model for the difference in restricted mean survival times. Biostatistics. 2021;22(1):82\u201396.","journal-title":"Biostatistics"},{"issue":"4","key":"8098_CR28","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1080\/10543406.2014.901341","volume":"24","author":"LM Chen","year":"2014","unstructured":"Chen LM, Ibrahim JG, Chu H. Flexible stopping boundaries when changing primary endpoints after unblinded interim analyses. J Biopharm Stat. 2014;24(4):817\u201333.","journal-title":"J Biopharm Stat"},{"key":"8098_CR29","doi-asserted-by":"publisher","unstructured":"AnsarinM, De Berardinis R, Corso F, Giugliano G, Bruschini R, De Benedetto L, Zorzi S, Maffini F, Sovardi F, Pigni C et al. Survival Outcomes in oral tongue cancer: a mono-institutional experience focusing on age. Front Oncol. 2021;11. https:\/\/doi.org\/10.3389\/fonc.2021.616653","DOI":"10.3389\/fonc.2021.616653"},{"key":"8098_CR30","doi-asserted-by":"publisher","unstructured":"BattistaRA, Pini GM, Finco A, Corso F, Galli A, Arrigoni G, Doglioni C, Callea M, Paccagnella M, Porcu L et al. From tumor macroenvironment to tumor microenvironment: the prognostic role of the immune system in oral and lung squamous cell carcinoma. Cancers (Basel). 2024;16(15). https:\/\/doi.org\/10.3390\/cancers16152759","DOI":"10.3390\/cancers16152759"},{"issue":"1","key":"8098_CR31","first-page":"21","volume":"21","author":"S Bobdey","year":"2017","unstructured":"Bobdey S, Ganesh B, Mishra P, Jain A. Role of monocyte count and neutrophil-to-lymphocyte ratio in survival of oral cancer patients. Int Arch Otorhinolaryngol. 2017;21(1):21\u20137.","journal-title":"Int Arch Otorhinolaryngol"},{"issue":"2","key":"8098_CR32","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/hed.25495","volume":"41","author":"F Chen","year":"2019","unstructured":"Chen F, Lin L, Liu F, Yan L, Qiu Y, Wang J, Hu Z, Wu J, Bao X, Lin L, et al. Three prognostic indexes as predictors of response to adjuvant chemoradiotherapy in patients with oral squamous cell carcinoma after radical surgery: a large-scale prospective study. Head Neck. 2019;41(2):301\u20138.","journal-title":"Head Neck"},{"issue":"5","key":"8098_CR33","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1111\/odi.13629","volume":"27","author":"L Chen","year":"2021","unstructured":"Chen L, Qian J, Lin L, Lin J, Chen Q, Zhuang Z, Hong Y, Wang J, Qiu Y, Pan L, et al. Prognostic value of preoperative lymphocyte-to-monocyte ratio in oral cancer patients and establishment of a dynamic nomogram. Oral Dis. 2021;27(5):1127\u201336.","journal-title":"Oral Dis"},{"issue":"1","key":"8098_CR34","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/s12967-018-1742-x","volume":"16","author":"P Diao","year":"2018","unstructured":"Diao P, Wu Y, Li J, Zhang W, Huang R, Zhou C, Wang Y, Cheng J. Preoperative systemic immune-inflammation index predicts prognosis of patients with oral squamous cell carcinoma after curative resection. J Transl Med. 2018;16(1):365.","journal-title":"J Transl Med"},{"key":"8098_CR35","doi-asserted-by":"publisher","unstructured":"DingM, Song Y, Jing J, Tian M, Ding L, Li Q, Zhou C, Dong H, Ni Y, Mou Y. The Ratio of Preoperative Serum Biomarkers Predicts Prognosis in Patients With Oral Squamous Cell Carcinoma. Front Oncol 2021;11. https:\/\/doi.org\/10.3389\/fonc.2021.719513","DOI":"10.3389\/fonc.2021.719513"},{"issue":"1","key":"8098_CR36","doi-asserted-by":"publisher","first-page":"405","DOI":"10.21873\/anticanres.13126","volume":"39","author":"K Furukawa","year":"2019","unstructured":"Furukawa K, Kawasaki G, Naruse T, Umeda M. Prognostic significance of pretreatment lymphocyte-to-monocyte ratio in patients with tongue cancer. Anticancer Res. 2019;39(1):405\u201312.","journal-title":"Anticancer Res"},{"issue":"1","key":"8098_CR37","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1186\/s12885-020-07063-1","volume":"20","author":"T Hasegawa","year":"2020","unstructured":"Hasegawa T, Iga T, Takeda D, Amano R, Saito I, Kakei Y, Kusumoto J, Kimoto A, Sakakibara A, Akashi M. Neutrophil-lymphocyte ratio associated with poor prognosis in oral cancer: a retrospective study. BMC Cancer. 2020;20(1):568.","journal-title":"BMC Cancer"},{"key":"8098_CR38","doi-asserted-by":"publisher","unstructured":"Huang CH, Chou YF, Hsieh TC, Chen PR. Association of Neutrophil-to-Lymphocyte Ratio and Bloodstream Infections with Survival after Curative-Intent Treatment in Elderly Patients with Oral Cavity Squamous Cell Carcinoma. Diagnostics (Basel). 2023;13(3). https:\/\/doi.org\/10.3390\/diagnostics13030493","DOI":"10.3390\/diagnostics13030493"},{"issue":"9","key":"8098_CR39","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1016\/j.joms.2019.03.007","volume":"77","author":"\u00daM Jariod-Ferrer","year":"2019","unstructured":"Jariod-Ferrer \u00daM, Arbones-Mainar JM, Gavin-Clavero MA, Sim\u00f3n-Sanz MV, Moral-Saez I, Cisneros-Gimeno AI, Martinez-Trufero J. Are comorbidities associated with overall survival in patients with oral squamous cell carcinoma? J Oral Maxillofac Surg. 2019;77(9):1906\u201314.","journal-title":"J Oral Maxillofac Surg"},{"issue":"1","key":"8098_CR40","doi-asserted-by":"publisher","first-page":"12111","DOI":"10.1038\/s41598-020-68991-3","volume":"10","author":"S Lee","year":"2020","unstructured":"Lee S, Kim DW, Kwon S, Kim HJ, Cha IH, Nam W. Prognostic value of systemic inflammatory markers for oral cancer patients based on the 8th edition of AJCC staging system. Sci Rep. 2020;10(1):12111.","journal-title":"Sci Rep"},{"issue":"1","key":"8098_CR41","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1186\/s12903-021-02028-7","volume":"21","author":"YW Lin","year":"2021","unstructured":"Lin YW, Kang WP, Huang BL, Qiu ZH, Wei LF, Zhang B, Ding TY, Luo Y, Liu CT, Chu LY, et al. Nomogram based on clinical characteristics and serological inflammation markers to predict overall survival of oral tongue squamous cell carcinoma patient after surgery. BMC Oral Health. 2021;21(1):667.","journal-title":"BMC Oral Health"},{"key":"8098_CR42","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12885-016-2079-6","volume":"16","author":"H Nakashima","year":"2016","unstructured":"Nakashima H, Matsuoka Y, Yoshida R, Nagata M, Hirosue A, Kawahara K, Sakata J, Arita H, Hiraki A, Nakayama H. Pre-treatment neutrophil to lymphocyte ratio predicts the chemoradiotherapy outcome and survival in patients with oral squamous cell carcinoma: a retrospective study. BMC Cancer. 2016;16:41.","journal-title":"BMC Cancer"},{"key":"8098_CR43","doi-asserted-by":"publisher","unstructured":"NieZ, Zhao P, Shang Y, Sun B. Nomograms to predict the prognosis in locally advanced oral squamous cell carcinoma after curative resection. BMC Cancer 2021;21(1). https:\/\/doi.org\/10.1186\/s12885-021-08106-x","DOI":"10.1186\/s12885-021-08106-x"},{"issue":"2","key":"8098_CR44","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s10006-023-01191-1","volume":"28","author":"Y Ohyama","year":"2024","unstructured":"Ohyama Y, Inaba Y, Kubota M, Kanemaru T, Hasegawa K. CT-assessed sarcopenia and prognostic nutritional index are associated with poor prognosis in oral squamous cell carcinoma. Oral Maxillofac Surg. 2024;28(2):659\u201366.","journal-title":"Oral Maxillofac Surg"},{"issue":"5","key":"8098_CR45","doi-asserted-by":"publisher","first-page":"305","DOI":"10.5125\/jkaoms.2017.43.5.305","volume":"43","author":"JW Park","year":"2017","unstructured":"Park JW, Kim C-H, Ha YC, Kim MY, Park SM. Count of platelet and mean platelet volume score: serologic prognostic factor in patients with oral squamous cell carcinoma. J Korean Association Oral Maxillofacial Surg. 2017;43(5):305\u201311.","journal-title":"J Korean Association Oral Maxillofacial Surg"},{"key":"8098_CR46","doi-asserted-by":"publisher","first-page":"941351","DOI":"10.3389\/fimmu.2022.941351","volume":"13","author":"M Ruiz-Ranz","year":"2022","unstructured":"Ruiz-Ranz M, Lequerica-Fern\u00e1ndez P, Rodr\u00edguez-Santamarta T, Su\u00e1rez-S\u00e1nchez FJ, L\u00f3pez-Pintor RM, Garc\u00eda-Pedrero JM, de Vicente JC. Prognostic implications of preoperative systemic inflammatory markers in oral squamous cell carcinoma, and correlations with the local immune tumor microenvironment. Front Immunol. 2022;13:941351.","journal-title":"Front Immunol"},{"issue":"4","key":"8098_CR47","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1177\/0194599817745284","volume":"158","author":"Y Sano","year":"2018","unstructured":"Sano Y, Kogashiwa Y, Araki R, Enoki Y, Ikeda T, Yoda T, Nakahira M, Sugasawa M. Correlation of inflammatory markers, survival, and COX2 expression in oral cancer and implications for prognosis. Otolaryngol Head Neck Surg. 2018;158(4):667\u201376.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"8098_CR48","doi-asserted-by":"publisher","first-page":"12329","DOI":"10.2147\/CMAR.S277927","volume":"12","author":"W Sun","year":"2020","unstructured":"Sun W, Gao M, Hu G, Yuan X. Inflammatory marker predicts outcome of oral squamous cell carcinoma receiving chemo-radiotherapy. Cancer Manage Res. 2020;12:12329\u201335.","journal-title":"Cancer Manage Res"},{"issue":"3","key":"8098_CR49","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/lio2.790","volume":"7","author":"P Supanimitjaroenporn","year":"2022","unstructured":"Supanimitjaroenporn P, Kirtsreesakul V, Tangthongkum M, Leelasawatsuk P, Prapaisit U. Prognostic value of pretreatment lymphocyte-to-monocyte ratio in patients with advanced oral cavity cancer. Laryngoscope Investig Otolaryngol. 2022;7(3):740\u20135.","journal-title":"Laryngoscope Investig Otolaryngol"},{"key":"8098_CR50","doi-asserted-by":"publisher","unstructured":"TrevisaniLFM, Kulcsar IF, Kulcsar MAV, Dedivitis RA, Kowalski LP, Matos LL. Prognostic Value of Hematological Parameters in Oral Squamous Cell Carcinoma. Cancers 2023;15(21). https:\/\/doi.org\/10.3390\/cancers15215245","DOI":"10.3390\/cancers15215245"},{"key":"8098_CR51","doi-asserted-by":"publisher","first-page":"825967","DOI":"10.3389\/fonc.2022.825967","volume":"12","author":"YT Tsai","year":"2022","unstructured":"Tsai YT, Fang KH, Hsu CM, Lai CH, Chang SW, Huang EI, Tsai MS, Chang GH, Luan CW. Prognostic role of high-sensitivity modified glasgow prognostic score for patients with operated oral cavity cancer: a retrospective study. Front Oncol. 2022;12:825967.","journal-title":"Front Oncol"},{"key":"8098_CR52","doi-asserted-by":"publisher","unstructured":"Tsai YT, Hsu CM, Chang GH, Tsai MS, Lee YC, Huang EI, Lai CH, Fang KH. Advanced lung cancer inflammation index predicts survival outcomes of patients with oral cavity cancer following curative surgery. Front Oncol 2021, 11 (no pagination). https:\/\/doi.org\/10.3389\/fonc.2021.609314","DOI":"10.3389\/fonc.2021.609314"},{"issue":"1","key":"8098_CR53","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00405-020-06145-x","volume":"278","author":"YT Wang","year":"2021","unstructured":"Wang YT, Fang KH, Hsu CM, Chang GH, Lai CH, Lee YC, Tsai MS, Huang EI, Tsai YT. Retrospective study on the potential of albumin\/globulin ratio as a prognostic biomarker for oral cavity cancer patients. Eur Arch Otorhinolaryngol. 2021;278(1):227\u201338.","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"11","key":"8098_CR54","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.ijom.2021.01.009","volume":"50","author":"Y Watabe","year":"2021","unstructured":"Watabe Y, Aoki K, Ichikawa H, Matsuzaki H, Ito A, Tanaka JI, Kamiyama I, Shigematsu S. A preoperative prognostic nutritional index is a prognostic indicator in oral squamous cell carcinoma patients undergoing radical surgery. Int J Oral Maxillofac Surg. 2021;50(11):1413\u201321.","journal-title":"Int J Oral Maxillofac Surg"},{"key":"8098_CR55","doi-asserted-by":"publisher","first-page":"153303382110430","DOI":"10.1177\/15330338211043048","volume":"20","author":"LF Wei","year":"2021","unstructured":"Wei LF, Huang XC, Lin YW, Luo Y, Ding TY, Liu CT, Chu LY, Xu YW, Peng YH, Guo HP. A prognostic model based on clinicopathological features and inflammation- and nutrition-related indicators predicts overall survival in surgical patients with tongue squamous cell carcinoma. Technol Cancer Res Treat. 2021;20:15330338211043048.","journal-title":"Technol Cancer Res Treat"},{"key":"8098_CR56","doi-asserted-by":"publisher","first-page":"3917","DOI":"10.2147\/OTT.S140800","volume":"10","author":"CN Wu","year":"2017","unstructured":"Wu CN, Chuang HC, Lin YT, Fang FM, Li SH, Chien CY. Prognosis of neutrophil-to-lymphocyte ratio in clinical early-stage tongue (cT1\/T2N0) cancer. Onco Targets Ther. 2017;10:3917\u201324.","journal-title":"Onco Targets Ther"},{"key":"8098_CR57","doi-asserted-by":"publisher","unstructured":"Wu HX, Cheng S, Liu F, Lin JJ, Huang SN, Wang CL, Zhou B, Liu ZQ, Cao MH. Nomogram incorporating potent inflammatory indicators for overall survival estimation of patients with primary oral squamous cell carcinoma. Front Oncol 2023, 13(no pagination). https:\/\/doi.org\/10.3389\/fonc.2023.1197049","DOI":"10.3389\/fonc.2023.1197049"},{"issue":"6","key":"8098_CR58","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1002\/cam4.3738","volume":"10","author":"YY Wu","year":"2021","unstructured":"Wu YY, Chang KP, Ho TY, Chou WC, Hung SP, Fan KH, Chiang YY, Chou YC, Tsang NM. Comparative prognostic value of different preoperative complete blood count cell ratios in patients with oral cavity cancer treated with surgery and postoperative radiotherapy. Cancer Med. 2021;10(6):1975\u201388.","journal-title":"Cancer Med"},{"key":"8098_CR59","doi-asserted-by":"publisher","unstructured":"Zakaria SS, Ramanathan A, Ripen ZM, Ghani WMN, Yang Y-H, Vincent-Chong VK, Ismail SM. Prognostic abilities of pre- and post-treatment inflammatory markers in oral squamous cell carcinoma: stepwise modelling. medicina-lithuania 2022, 58(10). https:\/\/doi.org\/10.3390\/medicina58101426","DOI":"10.3390\/medicina58101426"},{"issue":"1","key":"8098_CR60","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00405-021-06786-6","volume":"279","author":"W Zhou","year":"2022","unstructured":"Zhou W, Peng C, Liu Z, Cao W. A novel clinical signature predicts the survival of elderly patients with oral squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2022;279(1):391\u20138.","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"5","key":"8098_CR61","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.bjoms.2021.10.017","volume":"60","author":"F Zubair","year":"2022","unstructured":"Zubair F, McMahon J, Kryklyas G, Wicks C. Systemic inflammatory response in predicting outcomes of patients undergoing curative resection for oral squamous cell carcinoma. Br J Oral Maxillofac Surg. 2022;60(5):589\u201395.","journal-title":"Br J Oral Maxillofac Surg"},{"key":"8098_CR62","doi-asserted-by":"publisher","first-page":"1652603","DOI":"10.3389\/fgene.2025.1652603","volume":"16","author":"A Cheng","year":"2025","unstructured":"Cheng A, Wei K, Xu Q, Wang C, Li B, Liu H, Zhang L, Zhou H, Huang Y, Zhang Y, et al. The comparison of the prognostic value of different inflammation-related indicators in patients with oral squamous cell carcinoma. Front Genet. 2025;16:1652603.","journal-title":"Front Genet"},{"key":"8098_CR63","doi-asserted-by":"publisher","first-page":"1676824","DOI":"10.3389\/fonc.2025.1676824","volume":"15","author":"Z Li","year":"2025","unstructured":"Li Z, An W, Wang B, Yan Z, Gao L, Wang J, Yu H, Wen S. Prognostic significance of peripheral blood inflammatory biomarkers (SII, PLR, NLR, LMR, SIRI, PIV, PNI) in lip cancer: NLR as an independent biomarker for survival outcomes. Front Oncol. 2025;15:1676824.","journal-title":"Front Oncol"},{"issue":"7","key":"8098_CR64","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/hed.23400","volume":"36","author":"YD Tsai","year":"2014","unstructured":"Tsai YD, Wang CP, Chen CY, Lin LW, Hwang TZ, Lu LF, Hsu HF, Chung FM, Lee YJ, Houng JY. Pretreatment circulating monocyte count associated with poor prognosis in patients with oral cavity cancer. Head Neck. 2014;36(7):947\u201353.","journal-title":"Head Neck"},{"issue":"714","key":"8098_CR65","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.3399\/BJGP.2021.0282","volume":"72","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Walter FM, Mounce L, Abel GA, Singh H, Hamilton W, Stewart GD, Lyratzopoulos G. Identifying opportunities for timely diagnosis of bladder and renal cancer via abnormal blood tests: a longitudinal linked data study. Br J Gen Pract. 2022;72(714):e19\u201325.","journal-title":"Br J Gen Pract"},{"issue":"1","key":"8098_CR66","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1186\/s12967-025-06583-3","volume":"23","author":"S Bakrim","year":"2025","unstructured":"Bakrim S, Fessikh ME, Elhrech H, Omari NE, Amanullah M, Ming LC, Moshawih S, Bouyahya A. Targeting inflammation in cancer therapy: from mechanistic insights to emerging therapeutic approaches. J Transl Med. 2025;23(1):588.","journal-title":"J Transl Med"},{"issue":"6","key":"8098_CR67","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.jcms.2025.02.008","volume":"53","author":"C Liu","year":"2025","unstructured":"Liu C, Wang H, Wei K, Liu J, Li B, Feng Z, Wang C. The occurrence and impact of time to presentation for oral squamous cell carcinoma with curative surgery. J Craniomaxillofac Surg. 2025;53(6):705\u201313.","journal-title":"J Craniomaxillofac Surg"},{"key":"8098_CR68","doi-asserted-by":"publisher","first-page":"110107","DOI":"10.1016\/j.radonc.2024.110107","volume":"192","author":"MH Frank","year":"2024","unstructured":"Frank MH, van Dijk BAC, Schoonbeek RC, Zindler J, Devriese LA, van Es RJJ, Merkx MAW, de Bree R. Differences in the association of time to treatment initiation and survival according to various head and neck cancer sites in a nationwide cohort. Radiother Oncol. 2024;192:110107.","journal-title":"Radiother Oncol"},{"key":"8098_CR69","doi-asserted-by":"publisher","first-page":"108592","DOI":"10.1016\/j.biotechadv.2025.108592","volume":"82","author":"V Raju","year":"2025","unstructured":"Raju V, Reddy R, Javan AC, Hajihossainlou B, Weissleder R, Guiseppi-Elie A, Kurabayashi K, Jones SA, Faghih RT. Tracking inflammation status for improving patient prognosis: A review of current methods, unmet clinical needs and opportunities. Biotechnol Adv. 2025;82:108592.","journal-title":"Biotechnol Adv"},{"key":"8098_CR70","doi-asserted-by":"publisher","first-page":"5769","DOI":"10.2147\/JIR.S334941","volume":"14","author":"K Zheng","year":"2021","unstructured":"Zheng K, Liu X, Ji W, Lu J, Cui J, Li W. The efficacy of different inflammatory markers for the prognosis of patients with malignant tumors. J Inflamm Res. 2021;14:5769\u201385.","journal-title":"J Inflamm Res"},{"issue":"6","key":"8098_CR71","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.clnu.2022.04.019","volume":"41","author":"H Xie","year":"2022","unstructured":"Xie H, Ruan G, Ge Y, Zhang Q, Zhang H, Lin S, Song M, Zhang X, Liu X, Li X, et al. Inflammatory burden as a prognostic biomarker for cancer. Clin Nutr. 2022;41(6):1236\u201343.","journal-title":"Clin Nutr"},{"key":"8098_CR72","doi-asserted-by":"publisher","first-page":"1228076","DOI":"10.3389\/fonc.2023.1228076","volume":"13","author":"K Heshmat-Ghahdarijani","year":"2023","unstructured":"Heshmat-Ghahdarijani K, Sarmadi V, Heidari A, Falahati Marvasti A, Neshat S, Raeisi S. The neutrophil-to-lymphocyte ratio as a new prognostic factor in cancers: a narrative review. Front Oncol. 2023;13:1228076.","journal-title":"Front Oncol"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-026-08098-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-026-08098-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-026-08098-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:52:21Z","timestamp":1776919941000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12903-026-08098-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8098"],"URL":"https:\/\/doi.org\/10.1186\/s12903-026-08098-9","relation":{},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"assertion":[{"value":"21 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"724"}}